Clinical Trials
2 trialsNCT05907512 2023-06-22
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Fudan University
Phase 2 Unknown
NCT03095079 2017-03-29
Rh-endostatin in Combination With Dacarbazine and Cisplatin as the First Line Therapy for Metastatic Melanoma
Peking University Cancer Hospital & Institute
Phase 2 Unknown